Evidence map›Paper›PMID 35867975›Full record

SynthesisMedical mycology2022

Aspergillus spp. osteoarticular infections: an updated systematic review on the diagnosis, treatment and outcomes of 186 confirmed cases.

Andreas G Tsantes, Dimitrios V Papadopoulos, Eleftheria Markou, Konstantinos Zarokostas, Rozeta Sokou, Ioannis Trikoupis, Andreas F Mavrogenis, Dimitra Houhoula, Daniele Piovani, Stefanos Bonovas and 3 more

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Medical mycology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Osteoarticular Mycoses.Clinical microbiology reviews · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Andreas G TsantesDepartment of Microbiology, Medical School, National and Kapodistrian University of Athens, 15772 Athens, Greece.ORCID 0000-0002-3695-0759
Dimitrios V PapadopoulosDepartment of Orthopaedic Surgery, Geisinger Medical Center, Danville, PA 17821, US.
Eleftheria MarkouDepartment of Microbiology, University Hospital of Ioannina, Ioannina 45500, Greece.
Konstantinos ZarokostasDepartment of Microbiology, 'Saint Savvas' Oncology Hospital, 11522 Athens, Greece.
Rozeta SokouNeonatal Intensive Care Unit, "Agios Panteleimon" General Hospital of Nikea, Piraeus 18454, Greece.
Ioannis TrikoupisFirst Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens 15772, Greece.
Andreas F MavrogenisFirst Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens 15772, Greece.
Dimitra HouhoulaLaboratory of Haematology and Blood Bank Unit, "Attiko" Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens 15772, Greece.
Daniele PiovaniDepartment of Biomedical Sciences, Humanitas University, 20090 Pieve MI, Milan, Italy.
Stefanos BonovasDepartment of Biomedical Sciences, Humanitas University, 20090 Pieve MI, Milan, Italy.ORCID 0000-0001-6102-6579
Argirios E TsantesLaboratory of Haematology and Blood Bank Unit, "Attiko" Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens 15772, Greece.
Athanasios TsakrisDepartment of Microbiology, Medical School, National and Kapodistrian University of Athens, 15772 Athens, Greece.
Georgia VrioniDepartment of Microbiology, Medical School, National and Kapodistrian University of Athens, 15772 Athens, Greece.
National and Kapodistrian University of Athens · GRHumanitas University · ITGeisinger Medical Center · USSt Savas Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspergillus spp. osteoarticular infections are destructive opportunistic infections, while there is no clear consensus on their management. The purpose of this review is to investigate the current literature regarding Aspergillus spp. osteoarticular infections. An electronic search of the PubMed and Scopus databases was conducted considering studies that assessed osteoarticular infections from Aspergillus spp. We included only studies with biopsy proven documentation of positive cultures or histological findings for Aspergillus spp., and those with essential information for each case such as the anatomical location of the infection, the type of treatment (conservative, surgical, combination), the antifungal therapy, and the outcome. Overall, 148 studies from 1965 to 2021 including 186 patients were included in the review. One hundred and seven (57.5%) patients underwent surgical debridement in addition to antifungal therapy, while 79 (42.7%) patients were treated only conservatively. Complete infection resolution was reported in 107 (57.5%) patients, while partial resolution in 29 (15.5%) patients. Surgical debridement resulted in higher complete infection resolution rate compared to only antifungal therapy (70.0% vs. 40.5%, P < 0.001), while complete resolution rate was similar for antifungal monotherapy and combination/sequential therapy (58.3% vs. 54.5%; P = 0.76). Last, complete resolution rate was also similar for monotherapy with amphotericin B (58.1%) and voriconazole (58.6%; P = 0.95). The results of this study indicate that antifungal monotherapy has similar efficacy with combination/sequential therapy, while voriconazole has similar efficacy with amphotericin B. Moreover, surgical debridement of the infected focus results in better outcomes in terms of infection eradication compared to conservative treatment. LAY SUMMARY: Antifungal monotherapy has similar efficacy with combination/sequential therapy, and voriconazole has similar efficacy with amphotericin B for the treatment of Aspergillus spp. osteoarticular infections, while surgical debridement of the infected focus improves the infection eradication rate.

Indexed as

Amphotericin BAspergillosisAnimalsAntifungal AgentsAspergillusMicrobial Sensitivity TestsTreatment OutcomeVoriconazoleAmphotericin BAntifungal AgentsVoriconazoleantifungal agentsAspergillus sppdiagnosismanagementosteoarticular infection

Identifiers

PMID35867975
PMCPMC9849853
OpenAlexW4286717126

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.